Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2015
K562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes In VivoIgnazio Caruana, Gerrit Weber, Brandon C Ballard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2017
Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T CellsIulia Diaconu, Brandon Ballard, Ming Zhang, et al.
Journal for Immunotherapy of Cancer|September 14, 2021
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cellsJustin T Huckaby, Elisa Landoni, Timothy M Jacobs, et al.
Advances in Cell and Gene Therapy|September 9, 2022
Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T CellsSung Hyun Lee, Yajing Hao, Tong Gui, et al.
Nature Cancer|April 26, 2021
GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve visionKai Wang, Yuhui Chen, Sarah Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibitionSerena K Perna, Daria Pagliara, Aruna Mahendravada, et al.
Transplantation|December 11, 2012
Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipientsEric A Engels, Barbara Savoldo, Ruth M Pfeiffer, et al.
Plos One|December 25, 2015
Evaluation of Intracellular Signaling Downstream Chimeric Antigen ReceptorsHannah Karlsson, Emma Svensson, Camilla Gigg, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 25, 2024
Barcoding of viable peripheral blood mononuclear cells with selenium and tellurium isotopes for mass cytometry experimentsYoungran Seo, Ken Fowler, Leah M Flick, et al.
Cancer Immunology Research|August 9, 2018
CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30<sup>+</sup> and CD30<sup>-</sup> Embryonal Carcinoma via Antigen-Dependent and Fas/FasL InteractionsLee K Hong, Yuhui Chen, Christof C Smith, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2015
K562-Derived Whole-Cell Vaccine Enhances Antitumor Responses of CAR-Redirected Virus-Specific Cytotoxic T Lymphocytes In VivoIgnazio Caruana, Gerrit Weber, Brandon C Ballard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2017
Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T CellsIulia Diaconu, Brandon Ballard, Ming Zhang, et al.
Journal for Immunotherapy of Cancer|September 14, 2021
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cellsJustin T Huckaby, Elisa Landoni, Timothy M Jacobs, et al.
Advances in Cell and Gene Therapy|September 9, 2022
Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T CellsSung Hyun Lee, Yajing Hao, Tong Gui, et al.
Nature Cancer|April 26, 2021
GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve visionKai Wang, Yuhui Chen, Sarah Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Interleukin-7 mediates selective expansion of tumor-redirected cytotoxic T lymphocytes (CTLs) without enhancement of regulatory T-cell inhibitionSerena K Perna, Daria Pagliara, Aruna Mahendravada, et al.
Transplantation|December 11, 2012
Plasma markers of B-cell activation and clonality in pediatric liver and hematopoietic stem cell transplant recipientsEric A Engels, Barbara Savoldo, Ruth M Pfeiffer, et al.
Plos One|December 25, 2015
Evaluation of Intracellular Signaling Downstream Chimeric Antigen ReceptorsHannah Karlsson, Emma Svensson, Camilla Gigg, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 25, 2024
Barcoding of viable peripheral blood mononuclear cells with selenium and tellurium isotopes for mass cytometry experimentsYoungran Seo, Ken Fowler, Leah M Flick, et al.
Cancer Immunology Research|August 9, 2018
CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30<sup>+</sup> and CD30<sup>-</sup> Embryonal Carcinoma via Antigen-Dependent and Fas/FasL InteractionsLee K Hong, Yuhui Chen, Christof C Smith, et al.
Pageof 16